KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsBuildingsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Boston Scientific (BSX) Total Current Liabilities (2016 - 2025)

Boston Scientific's Total Current Liabilities history spans 17 years, with the latest figure at $5.4 billion for Q4 2025.

  • For Q4 2025, Total Current Liabilities fell 15.0% year-over-year to $5.4 billion; the TTM value through Dec 2025 reached $5.4 billion, down 15.0%, while the annual FY2025 figure was $5.4 billion, 15.0% down from the prior year.
  • Total Current Liabilities for Q4 2025 was $5.4 billion at Boston Scientific, up from $5.2 billion in the prior quarter.
  • Across five years, Total Current Liabilities topped out at $6.4 billion in Q4 2024 and bottomed at $3.8 billion in Q4 2022.
  • The 5-year median for Total Current Liabilities is $4.9 billion (2023), against an average of $4.9 billion.
  • The largest annual shift saw Total Current Liabilities rose 29.72% in 2024 before it dropped 15.0% in 2025.
  • A 5-year view of Total Current Liabilities shows it stood at $4.3 billion in 2021, then dropped by 11.02% to $3.8 billion in 2022, then increased by 29.71% to $4.9 billion in 2023, then grew by 29.72% to $6.4 billion in 2024, then fell by 15.0% to $5.4 billion in 2025.
  • Per Business Quant, the three most recent readings for BSX's Total Current Liabilities are $5.4 billion (Q4 2025), $5.2 billion (Q2 2025), and $5.1 billion (Q1 2025).